2nd Quarter - Report
AVENUE SOLUTIONS for GENENTECH USA, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicare Part B, CMS coverage and reimbursement; Issues related to healthcare access, quality and costs; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
Health Issues HCR
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to 340b drug pricing program
| Lobbyist | Covered position, as disclosed |
|---|---|
| TRACY SPICER | — |
| AMY TEJRAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.